Health Care: Drugs

OxiGene Inc (OXGN: NASDAQ)

$1.62 n/a | n/a%
12/19/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 95.00K 156.00K 0.00 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 95.00K 156.00K 0.00 0.00
Selling, General, and Administrative Expenses 4.74M 4.69M 5.38M 5.88M
Research & Development 3.64M 3.52M 5.29M 12.11M
Operating Income before D & A (EBITDA) -8.28M -8.06M -10.67M -18.00M
Depreciation & Amortization 110.00K 127.00K 150.00K 194.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 3.00K -7.00K 2.24M -5.26M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -8.39M -8.21M -9.80M -23.96M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -8.39M -8.21M -9.80M -23.96M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -8.28M -8.08M -9.65M -23.77M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -8.28M -8.08M -9.65M -23.77M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -8.28M -8.08M -9.65M -23.77M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-8.28M -8.06M -8.43M -23.26M
Preferred Dividends
Net Income Available To Common -13.08M -8.08M -9.65M -23.77M
Basic EPS from Continuing Ops. -4.67 -5.48 -10.37 -71.52
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -4.67 -5.48 -10.37 -71.52
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.05 0.00
Basic EPS, Total -4.67 -5.48 -10.32 -71.52
Basic Normalized Net Income/Share -4.67 -5.47 -9.06 -69.99
EPS fr Continuing Ops. -4.67 -5.48 -10.37 -71.52
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -4.67 -5.48 -10.37 -71.52
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.05 0.00
EPS, Total -4.67 -5.48 -10.32 -71.52
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-4.67 -5.47 -9.06 -69.99
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with OXGN

Latest OXGN Headlines from TheStreet

More Financial News for OXGN

Press Releases for OXGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter